ONMDONMDHealthcare · Health Information Services

ONMD Stock Forecast: OneMedNet Corp. Price Predictions for 2026-2027

Last close, 4 Nov 2026
$4.54
+7.84% on the day

Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 10 of 100 as at 4 Nov 2026 — in the weakest quartile.

Market cap
$24.5M
Ticker Nerd rank
10/ 100
Median analyst target
—
Analysts covering
—
Revenue$292K+88.4% y/y
Operating income−$2.3M
Net income−$2.2M
Free cash flow−$1.9M
Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown
Total return, dividends reinvested
1W
+1.8%
1M
−15.8%
YTD
−58.7%
1Y
−74.2%
From 52W high
−76.7%
From 52W low
+15.5%
$4
$20
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

ONMD stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores OneMedNet Corp. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 4 Nov 2026
10/ 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Size
85
Accruals
74
Growth
34
Revisions
25
Momentum
21
Volatility
14
Value
13
Issuance
6
Quality
3

Size (85): Smaller than most of the companies we track.

Quality (3): Profits are thin or unreliable for the size of the business, or they are not turning into cash.

Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.

Wall Street

ONMD stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on ONMD, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$5$10$15$20Jan 26Apr 26Jul 26Oct 26ONMD

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

ONMD appears in the Radar on the weeks it earns a place.

  • Market Radar, every Monday: the week's biggest rank moves across ~4,600 US stocks, and the reason for each.
  • The AI build-out map, free: every AI company we track, part by part, and one part in full with each verdict.

Free. Unsubscribe any time.

The AI build-out map
PDF
  • AI cloud capacity

    MSFTAMZNGOOGLORCL

  • AI chips

    NVDAAVGOAMDMU

  • AI networking and serversIn full

    ANETDELLLITECRDO

  • Data centre power

    VRTCEGGEVVST

Performance

ONMD vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 4 Nov 2026, OneMedNet Corp. returned −74.2% against +14.8% for the S&P 500, dividends included.

ONMD vs S&P 500, last 12 monthsTotal return, rebased to 100
20406080100120Jan 26Apr 26Jul 26Oct 26ONMDS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

ONMD analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Fundamentals

OneMedNet Corp. (ONMD) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
45.0×

Cheaper than 16% of US stocks

Price / sales
17.5×

Cheaper than 9% of US stocks

Price / book
−73.1×

Cheaper than 99% of US stocks

EV / EBITDA
−2.5×

Cheaper than 75% of US stocks

Growth & margins
Revenue growth (YoY)
88.4%

Higher than 91% of US stocks

Earnings growth (YoY)
88.4%

Higher than 82% of US stocks

Gross margin
−193.5%

Higher than 1% of US stocks

Operating margin
−774.3%

Higher than 6% of US stocks

Net margin
−37.0%

Higher than 12% of US stocks

Returns & dividend
Return on equity
94.5%

Higher than 96% of US stocks

Return on assets
−342.1%

Higher than 1% of US stocks

Dividend yield
0.0%

Higher than 1% of US dividend payers

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

OneMedNet Corp. (ONMD) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • OneMedNet Corp. has a market value of $24.5M and an enterprise value of $25.3M.

  • Revenue in the twelve months to 30 June 2026: $1.5M. The latest quarter grew 88.4% year on year.

  • Net income over the same four quarters: −$8.5M, a −584.2% net margin.

  • Free cash flow in the twelve months to 30 June 2026: −$6.9M.

  • Shares outstanding: 57.7M.

  • Trailing P/E: 45.0×.

  • Forward dividend yield: 0.00%, paying out 0% of earnings.

  • OneMedNet Corp. employs 22 people — $66K of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 4 Nov 2026

Data provided by Twelve Data

Peers

ONMD vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelHealth Information Services
CompanyMarket capTKN rank
ONMDOneMedNet Corp.$24.5M10
DRIODarioHealth Corp.$29.1M49
BEATHeartBeam, Inc.$23.9M26
CCLDCareCloud, Inc.$76.5M77
BFRGBullFrog AI Holdings, Inc.$9.7M47
LFMDLifeMD, Inc.$117.9M45
HCATHealth Catalyst, Inc.$119.7M57

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own OneMedNet Corp. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest ONMD news & analysis

OneMedNet Receives Mid Six-Figure Re-Order from Foundation Model Company Developing Radiology Models

GlobeNewsWire · 4 Nov 2026positive

OneMedNet announced a mid six-figure re-order from a previously announced foundation model company developing radiology AI models. The order follows delivery of the first dataset under the customer agreement, citing the data’s quality and completeness.

Why it matters — The re-order reflects a follow-on purchase tied to OneMedNet’s dataset delivery for a radiology AI customer.

OneMedNet Receives High Six-Figure Add-On Order Under Multiyear Agreement Announced September 30

GlobeNewsWire · 3 Nov 2026positive

OneMedNet said it received a high six-figure add-on order under the multiyear agreement announced September 30, 2026. The order exercises an expansion option and increases data volume by 150% for the commercially scaled AI-enabled precision medicine customer.

Why it matters — The order expands the scope of an existing customer agreement, a development ONMD watchers may track.

OneMedNet Signs Global Pharmaceutical Intelligence Provider as Channel Partner, Extending Reach in Pharma Market

GlobeNewsWire · 19 Oct 2026positive

OneMedNet announced its 12th channel partner agreement, under which a global pharmaceutical intelligence and data provider will distribute the company’s U.S.-sourced, de-identified clinical data to pharmaceutical customers worldwide.

Why it matters — The agreement extends OneMedNet’s reach among pharmaceutical customers and into the life sciences data market.

OneMedNet Adds Leading Hospital System Provider Network, Expanding By Up to 12 Hospitals

GlobeNewsWire · 15 Oct 2026positive

OneMedNet announced that a leading hospital system has joined its iRWD platform and federated provider network. The company expects the network to expand by up to 12 additional hospitals.

Why it matters — The partnership is expected to increase the scale and clinical depth of OneMedNet’s healthcare data network.

OneMedNet Signs Mediplexus as its 11th Channel Partner, Expanding the Company's Real World Data Footprint into Korea and the Asia Pacific Region

GlobeNewsWire · 7 Oct 2026positive

OneMedNet signed its 11th channel partner agreement, appointing Korean healthcare data company Mediplexus as distributor of its U.S.-sourced Real World Data in Korea. The company said the agreement expands its commercial reach into the broader Asia Pacific region.

Why it matters — The partnership adds a distribution channel in Korea and extends OneMedNet's stated Real World Data footprint into Asia Pacific.

FAQ

Frequently asked questions about ONMD stock

How does Ticker Nerd's model rank ONMD?

As at 4 Nov 2026, OneMedNet Corp. ranks 10 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Size (85 of 100).

What is the ONMD stock forecast for 2030?

No analyst covering OneMedNet Corp. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for ONMD are extrapolating price history, which says nothing about the business.

How has ONMD stock performed over the past year?

OneMedNet Corp. returned -74.2% over the 12 months to 4 Nov 2026, with dividends reinvested. Past performance does not indicate future returns.

What does OneMedNet Corp. do?

OneMedNet Corp. Class A Common Stock represents the publicly traded equity of OneMedNet Corp., a healthcare technology company focused on clinical imaging and real-world data services.

What is the latest news on ONMD?

The most recent item we track (GlobeNewsWire, 4 Nov 2026): "OneMedNet Receives Mid Six-Figure Re-Order from Foundation Model Company Developing Radiology Models". OneMedNet announced a mid six-figure re-order from a previously announced foundation model company developing radiology AI models. The order follows delivery of the first dataset under the customer agreement, citing the data’s quality and completeness.

Company

About OneMedNet Corp.

OneMedNet Corp. Class A Common Stock represents the publicly traded equity of OneMedNet Corp., a healthcare technology company focused on clinical imaging and real-world data services. OneMedNet provides digital medical image management, exchange, and sharing solutions used across healthcare and life sciences workflows. Its core offerings include iRWD, a platform designed to securely de-identify, curate, search, and share imaging data for medical institutions, research organizations, and industry partners. The company also supports the movement of clinical images and related patient data between providers, hospitals, and research networks. OneMedNet serves customers in the Americas, Europe, and the Middle East, positioning itself within the health information services segment of the market. The stock is associated with a company whose products are centered on imaging data access, regulatory-grade data handling, and clinical research support.

CEO Mr. Aaron Green · 22 employees · United States · https://www.onemednet.com